» Articles » PMID: 14610394

Incidence of Lung, Eye, and Skin Lesions As Late Complications in 34,000 Iranians with Wartime Exposure to Mustard Agent

Overview
Date 2003 Nov 12
PMID 14610394
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Approximately 34,000 Iranians known to have sustained mustard agent exposure during the Iran-Iraq war of 1980-1988 and survived over a decade afterwards were screened for distribution of the most commonly occurring medical problems. In order of greatest incidence, these include lesions of the lungs (42.5%), eyes (39.3%), and skin (24.5%). Within each subpopulation, patients were ranked according to severity of lesions. Twenty-three percent to 37% of patients exhibited at least mild coverage, with 1.5% to 4.5% classed as moderate, and a much smaller population (0.023-1.0%) of the 34,000 patients exhibiting extensive (severe) lesional coverage. These results provide a comprehensive overview of the medical problem most common among mustard victims and could serve as a predictor of the likely impact of these weapons on health status of populations exposed to them during ongoing military conflicts.

Citing Articles

Long-term pulmonary complications in sulfur mustard-exposed patients: gene expression and DNA methylation of OGG1.

Zamani M, Ghazanfari T Bioimpacts. 2025; 15:27735.

PMID: 39963564 PMC: 11830137. DOI: 10.34172/bi.2023.27735.


Aftermath of Sulfur Mustard Poisoning.

Milner S Eplasty. 2024; 24:QA22.

PMID: 39502137 PMC: 11537709.


Factors affecting ocular trauma in Iran: A systematic review study.

Mir A, Baseri M, Kalan Farmanfarma K Health Sci Rep. 2024; 7(9):e2281.

PMID: 39221056 PMC: 11362837. DOI: 10.1002/hsr2.2281.


Pulmonary rehabilitation in Iranian outpatients with mustard gas lung disease: a randomised controlled trial.

Ghanei M, Philip K, Moghadam M, Hosseini H, Babaie A, Roustanezhad M BMJ Open. 2024; 14(5):e083085.

PMID: 38806414 PMC: 11138312. DOI: 10.1136/bmjopen-2023-083085.


A 39 Year mortality study of survivors exposed to sulfur mustard agent: A survival analysis.

Amini H, Solaymani-Dodaran M, Ghanei M, Abolghasemi J, Salesi M, Vahedian Azimi A Heliyon. 2024; 10(2):e24535.

PMID: 38312548 PMC: 10835181. DOI: 10.1016/j.heliyon.2024.e24535.